WIS
VRTX icon

Wright Investors Service’s Vertex Pharmaceuticals VRTX Stock Holding History

Wright Investors Service’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,241
Closed -$602K – 154
2025
Q1 		$602K Buy
+1,241
New +$578K 0.2% 96
2024
Q3 		– Sell
-3,373
Closed -$1.58M – 157
2024
Q2 		$1.58M Sell
3,373
-8
-0.2% -$3.47K 0.42% 71
2024
Q1 		$1.41M Buy
3,381
+1,960
+138% +$829K 0.36% 84
2023
Q4 		$578K Buy
+1,421
New +$525K 0.16% 116
2022
Q2 		– Sell
-1,497
Closed -$391K – 173
2022
Q1 		$391K Buy
+1,497
New +$355K 0.1% 136
2021
Q2 		– Sell
-4,149
Closed -$892K – 153
2021
Q1 		$892K Buy
4,149
+2,719
+190% +$597K 0.27% 98
2020
Q4 		$338K Buy
+1,430
New +$328K 0.12% 139
2013
Q3 		– Sell
-3,155
Closed -$253K – 223
2013
Q2 		$253K Buy
+3,155
New +$232K 0.12% 192

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wright Investors Service's VRTX Position: Q2 2025 in Review

Wright Investors Service sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 1,241 shares — an estimated $602K sold.

Wright Investors Service first reported a position in VRTX in Q2 2013 and held it in 8 quarters. The position peaked at $1.58M in Q2 2024. 1,562 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Wright Investors Service reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Wright Investors Service sold 1,241 Vertex Pharmaceuticals shares in Q2 2025, an estimated $602K.
  • Wright Investors Service first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Wright Investors Service's Vertex Pharmaceuticals position peaked at $1.58M in Q2 2024.
  • 1,562 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Wright Investors Service's 13F filing for Q2 2025, filed 11 Jul 2025.